Blocking cathepsin G and cathepsin K significantly reduces tumor-induced osteolysis, which suggests that cathepsin K and cathepsin G are crucial in the microenvironment of cancer-induced osteolytic lesions [10, 12]. The gene discussed is CTSK; the disease is cancer.